Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,372 | 118,218 | 128,030 | 171,498 | 145,220 |
| Marketable Securities | 167,461 | 111,959 | 128,519 | 109,843 | 158,367 |
| Receivables | 41,907 | 36,292 | 37,818 | 28,459 | 27,151 |
| TOTAL | $355,502 | $284,476 | $315,092 | $332,453 | $350,413 |
| Non-Current Assets | |||||
| PPE Net | 903 | 952 | 1,039 | 1,102 | 1,145 |
| Other Non-Current Assets | 42,440 | 42,743 | 44,115 | 43,809 | 41,363 |
| TOTAL | $43,343 | $43,695 | $45,154 | $44,911 | $42,508 |
| Total Assets | $398,845 | $328,171 | $360,246 | $377,364 | $392,921 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,320 | 7,499 | 11,815 | 10,848 | 11,085 |
| Accrued Expenses | 21,435 | 19,936 | 27,570 | 24,106 | 22,782 |
| TOTAL | $26,755 | $27,435 | $39,385 | $34,954 | $33,867 |
| Non-Current Liabilities | |||||
| Long Term Debt | 76,500 | 76,800 | 75,700 | 74,000 | 73,300 |
| Other Non-Current Liabilities | 8,625 | 8,773 | 8,917 | 9,020 | 9,148 |
| TOTAL | $85,125 | $85,573 | $84,617 | $83,020 | $82,448 |
| Total Liabilities | $111,880 | $113,008 | $124,002 | $117,974 | $116,315 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,314 | 113,044 | 100,306 | 97,629 | 97,403 |
| Common Shares | 309 | 277 | 273 | 271 | 266 |
| Retained earnings | -834,807 | -790,991 | -752,945 | -716,108 | -677,460 |
| Other shareholders' equity | 1,595 | 1,623 | 1,493 | 779 | 946 |
| TOTAL | $286,965 | $215,163 | $236,244 | $259,390 | $276,606 |
| Total Liabilities And Equity | $398,845 | $328,171 | $360,246 | $377,364 | $392,921 |